Beijing Strong Biotechnologies Inc Market Cap ($1.09 Billion)
Market Cap & Net Worth: Beijing Strong Biotechnologies Inc (300406)
Beijing Strong Biotechnologies Inc market cap. Beijing Strong Biotechnologies Inc (SHE:300406) has a market capitalization of $1.09 Billion (CN¥7.43 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #8277 globally and #1865 in its home market, demonstrating a 1.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Strong Biotechnologies Inc's stock price CN¥12.67 by its total outstanding shares 586308628 (586.31 Million). Also see cash efficiency ratio of Beijing Strong Biotechnologies Inc for how efficiently the company converts equity into cash flow.
Beijing Strong Biotechnologies Inc Market Cap History (2015–2026)
Beijing Strong Biotechnologies Inc market cap history from 2015 to 2026. Data shows change from $1.86 Billion to $1.09 Billion (-2.90% CAGR). Check Beijing Strong Biotechnologies Inc (300406) share price today for real-time trading data and today's change.
Beijing Strong Biotechnologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Strong Biotechnologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Beijing Strong Biotechnologies Inc equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.69x
Beijing Strong Biotechnologies Inc's market cap is 0.69 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.15x
Beijing Strong Biotechnologies Inc's market cap is 2.15 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.86 Billion | $566.20 Million | $245.04 Million | 3.29x | 7.61x |
| 2016 | $1.76 Billion | $667.40 Million | $271.65 Million | 2.64x | 6.48x |
| 2017 | $1.22 Billion | $694.28 Million | $273.15 Million | 1.76x | 4.48x |
| 2018 | $807.68 Million | $774.18 Million | $300.67 Million | 1.04x | 2.69x |
| 2019 | $1.35 Billion | $840.86 Million | $331.65 Million | 1.60x | 4.07x |
| 2020 | $2.09 Billion | $848.12 Million | $112.28 Million | 2.47x | 18.62x |
| 2021 | $1.66 Billion | $1.60 Billion | $405.65 Million | 1.04x | 4.10x |
| 2022 | $1.38 Billion | $1.51 Billion | $389.10 Million | 0.92x | 3.56x |
| 2023 | $1.62 Billion | $1.74 Billion | $523.74 Million | 0.93x | 3.10x |
| 2024 | $1.15 Billion | $1.66 Billion | $532.64 Million | 0.69x | 2.15x |
Competitor Companies of 300406 by Market Capitalization
Companies near Beijing Strong Biotechnologies Inc in the global market cap rankings as of November 5, 2026. Also see Beijing Strong Biotechnologies Inc asset portfolio for a full breakdown of the balance sheet.
Key companies related to Beijing Strong Biotechnologies Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #138 globally with a market cap of $165.94 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #505 globally with a market cap of $53.86 Billion USD ( CN¥368.05 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $706.16 |
| #138 | Danaher Corporation | NYSE:DHR | $165.94 Billion | $234.93 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $391.03 |
| #505 | WuXi AppTec Co Ltd | SHG:603259 | $53.86 Billion | CN¥148.81 |
Market Capitalization of Beijing Strong Biotechnologies Inc (2015–2026)
Market capitalization of Beijing Strong Biotechnologies Inc from 2015 to today. Between 2015 and today, Beijing Strong Biotechnologies Inc's market cap moved from $1.86 Billion to $ 1.09 Billion, with a yearly change of -2.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.09 Billion | -3.06% |
| 2025 | CN¥1.12 Billion | -2.17% |
| 2024 | CN¥1.15 Billion | -29.30% |
| 2023 | CN¥1.62 Billion | +17.19% |
| 2022 | CN¥1.38 Billion | -16.90% |
| 2021 | CN¥1.66 Billion | -20.38% |
| 2020 | CN¥2.09 Billion | +55.09% |
| 2019 | CN¥1.35 Billion | +66.93% |
| 2018 | CN¥807.68 Million | -33.93% |
| 2017 | CN¥1.22 Billion | -30.58% |
| 2016 | CN¥1.76 Billion | -5.52% |
| 2015 | CN¥1.86 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Beijing Strong Biotechnologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.09 Billion USD |
| MoneyControl | $1.09 Billion USD |
| MarketWatch | $1.09 Billion USD |
| marketcap.company | $1.09 Billion USD |
| Reuters | $1.09 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Strong Biotechnologies Inc
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more